NVO
Novo Nordisk
NVO
NVO
Delisted
NVO was delisted on the 15th of May, 2026.
1,477 hedge funds and large institutions have $21.3B invested in Novo Nordisk in 2025 Q2 according to their latest regulatory filings, with 137 funds opening new positions, 580 increasing their positions, 567 reducing their positions, and 161 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $23B → $21.3B (-$1.66B)
15% less first-time investments, than exits
New positions opened: 137 | Existing positions closed: 161
30% less call options, than puts
Call options by funds: $1.14B | Put options by funds: $1.63B
Holders
1,477
Holding in Top 10
25
Calls
$1.14B
Puts
$1.63B
Top Buyers
| 1 | +$293M | |
| 2 | +$144M | |
| 3 | +$134M | |
| 4 |
ClearBridge Investments
New York
|
+$108M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$84.8M |
Top Sellers
| 1 | -$332M | |
| 2 | -$236M | |
| 3 | -$220M | |
| 4 |
D.E. Shaw & Co
New York
|
-$176M |
| 5 |
JP Morgan Chase
New York
|
-$148M |